Neuroone Medical Technologies (NMTC) Accounts Payables (2014 - 2026)
Neuroone Medical Technologies (NMTC) posted Accounts Payables of $934196.0 for Q1 2026, up 69.14% on a QoQ basis from $552332.0 in Q4 2025, and up 2.57% year-over-year from $910754.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Accounts Payables (2014 - 2026) Analysis & Trends
Neuroone Medical Technologies' Accounts Payables history runs 13 years deep, the most recent figure standing at $934196.0 for Q1 2026.
- Quarterly Accounts Payables rose 2.57% year-over-year to $934196.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $934196.0 (up 2.57% YoY) and the FY2025 annual result came in at $1.0 million, down 1.83% from the prior year.
- Accounts Payables was $934196.0 for Q1 2026 at Neuroone Medical Technologies, up from $552332.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $1.0 million in Q3 2024 and bottomed at $325027.0 in Q2 2022.
- A 5-year average of $770995.7 and a median of $780839.0 in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables jumped 194.99% — and 2025, when it plunged 38.4%.
- Neuroone Medical Technologies' Accounts Payables stood at $861638.0 in 2022, then slipped by 11.8% to $760000.0 in 2023, then retreated by 2.04% to $744525.0 in 2024, then retreated by 25.81% to $552332.0 in 2025, then surged by 69.14% to $934196.0 in 2026.
- Business Quant data shows NMTC's Accounts Payables at $934196.0 in Q1 2026, $552332.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 934,196.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 934,196.00 |
| Dec 31, 2025 | 552,332.00 |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 467,734.00 |
| Mar 31, 2025 | 910,754.00 |
| Dec 31, 2024 | 744,525.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 759,260.00 |
| Mar 31, 2024 | 780,839.00 |
| Dec 31, 2023 | 760,000.00 |
| Sep 30, 2023 | 685,104.00 |
| Jun 30, 2023 | 958,811.00 |
| Mar 31, 2023 | 953,446.00 |
| Dec 31, 2022 | 861,638.00 |
| Sep 30, 2022 | 927,662.00 |
| Jun 30, 2022 | 325,027.00 |
| Mar 31, 2022 | 446,024.00 |
| Dec 31, 2021 | 703,718.00 |
| Sep 30, 2021 | 528,829.00 |
| Jun 30, 2021 | 296,410.00 |